XTLB logo

XTL Biopharmaceuticals (XTLB) Return On Assets

Annual ROA

-73.45%
-41.25%-128.11%

December 31, 2023

Summary

Performance

1-Year Change

-128.11%

3-Year Change

-61.68%

5-Year Change

-273.52%

15-Year Change

-519.31%

XTLB ROA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

25.78%
XTLB annual return on assets is higher than 25.78% of companies in Healthcare sector

High & Low

All-time High

361.82%
XTLB annual return on assets is currently -120.30% below its historical high of 361.82%

3-Year Low

-73.45%
XTLB annual return on assets is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
XTLB previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Apr 30, 2025
XTLB next annual earnings announcement is scheduled for Apr 30, 2025

OtherXTLBprofitabilitymetrics:

Annual Revenue

-
XTLB annual revenue value is unknown

Annual Net Income

-$1.78 M
XTLB annual net profit is -$1.78 million

Annual EPS

-$0.30
XTLB annual earnings per share is -$0.30

Annual ROE

-80.27%
XTLB annual return on equity is -80.27%

Quarterly ROA

-26.81%
+0.19%+0.70%

September 30, 2024

Summary

Performance

3-Month Change

+0.7%

1-Year Change

-101.73%

3-Year Change

-101.73%

5-Year Change

+20.21%

XTLB Quarterly ROA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

57.49%
XTLB quarterly return on assets is higher than 57.49% of companies in Healthcare sector

High & Low

All-time High

155.53%
XTLB quarterly return on assets is currently -117.24% below its historical high of 155.53%

3-Year Low

-67.77%

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
XTLB previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Apr 30, 2025
XTLB next earnings announcement is scheduled for Apr 30, 2025

OtherXTLBprofitabilitymetrics:

Quarterly Revenue

$162.00 K
XTLB quarterly revenue is $162.00 thousand

Quarterly Net Income

-$553.00 K
XTLB quarterly net profit is -$553.00 thousand

Quarterly EPS

-$0.16
XTLB quarterly earnings per share is -$0.16

Quarterly ROE

-34.34%
XTLB quarterly return on equity is -34.34%

ROA Formula

ROA =  Net Income
Total Assets ✕ 100%

Annual ROA

-73.45%
XTLB annual return on assets is -73.45%

Annual Net Income

-$1.78 M
XTLB annual net profit is -$1.78 million

Annual Total Assets

$2.43 M
XTLB annual total assets is $2.43 million

XTLB ROA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-128.1%-101.7%
3 y3 years-61.7%-101.7%
5 y5 years-273.5%+20.2%

XTLB ROA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-1218.0%at low-210.3%+60.4%
5 y5-year-1218.0%at low-210.3%+60.4%
alltimeall time-120.3%+65.1%-117.2%+89.6%

XTL Biopharmaceuticals ROA History

DateAnnualQuarterly
Sep 2024
-
-26.81%(-0.7%)
Jun 2024
-
-27.00%(+103.2%)
Mar 2024
-
-13.29%(-76.9%)
Dec 2023
-73.45%(+128.1%)
-57.57%(-8.0%)
Sep 2023
-
-62.57%(-7.7%)
Jun 2023
-
-67.77%(+21.1%)
Mar 2023
-
-55.95%(+133.1%)
Dec 2022
-32.20%(-590.1%)
-24.00%(-198.7%)
Sep 2022
-
24.31%(+4.9%)
Jun 2022
-
23.18%(+142.7%)
Mar 2022
-
9.55%(+49.9%)
Dec 2021
6.57%(-114.5%)
6.37%(-115.8%)
Sep 2021
-
-40.42%(-5.4%)
Jun 2021
-
-42.74%(+2.5%)
Mar 2021
-
-41.68%(-4.1%)
Dec 2020
-45.43%(+329.4%)
-43.46%(+29.3%)
Sep 2020
-
-33.60%(-3.2%)
Jun 2020
-
-34.71%(-30.4%)
Mar 2020
-
-49.87%(+502.3%)
Dec 2019
-10.58%(-125.0%)
-8.28%(-152.7%)
Sep 2019
-
15.70%(-62.7%)
Jun 2019
-
42.07%(-47.5%)
Mar 2019
-
80.17%(+56.8%)
Dec 2018
42.33%(-456.9%)
51.13%(+78.2%)
Sep 2018
-
28.70%(-23.0%)
Jun 2018
-
37.27%(+142.3%)
Mar 2018
-
15.38%(-223.6%)
Dec 2017
-11.86%(-85.9%)
-12.44%(-63.8%)
Sep 2017
-
-34.37%(-53.0%)
Jun 2017
-
-73.09%(+18.9%)
Mar 2017
-
-61.45%(+3.8%)
Dec 2016
-84.36%(+4.2%)
-59.21%(-17.0%)
Sep 2016
-
-71.36%(+10.0%)
Jun 2016
-
-64.88%(+3.6%)
Mar 2016
-
-62.62%(-9.0%)
Dec 2015
-80.99%(+59.6%)
-68.81%(+47.4%)
Sep 2015
-
-46.68%(-2.9%)
Jun 2015
-
-48.09%(-4.5%)
Mar 2015
-
-50.37%(+24.2%)
Dec 2014
-50.76%
-40.56%(-21.8%)
Sep 2014
-
-51.89%(+43.3%)
Jun 2014
-
-36.20%(-5.9%)
DateAnnualQuarterly
Mar 2014
-
-38.47%(+1.9%)
Dec 2013
-46.33%(+269.5%)
-37.75%(+128.2%)
Sep 2013
-
-16.54%(-31.4%)
Jun 2013
-
-24.10%(+13.5%)
Mar 2013
-
-21.24%(+16.8%)
Dec 2012
-12.54%(-57.7%)
-18.19%(-17.1%)
Sep 2012
-
-21.94%(-25.4%)
Jun 2012
-
-29.41%(+20.8%)
Mar 2012
-
-24.35%(-10.9%)
Dec 2011
-29.63%(-10.5%)
-27.32%(-2.5%)
Sep 2011
-
-28.03%(-14.8%)
Jun 2011
-
-32.89%(-25.7%)
Mar 2011
-
-44.25%(-33.7%)
Dec 2010
-33.11%(-109.2%)
-66.79%(-29.6%)
Sep 2010
-
-94.82%(-36.6%)
Jun 2010
-
-149.50%(-274.9%)
Mar 2010
-
85.47%(-45.0%)
Dec 2009
361.82%(-272.1%)
155.53%(-160.4%)
Sep 2009
-
-257.54%(+29.5%)
Jun 2009
-
-198.85%(+10.2%)
Mar 2009
-
-180.42%(-3.3%)
Dec 2008
-210.25%(+72.9%)
-186.66%(+162.3%)
Sep 2008
-
-71.16%(-34.1%)
Jun 2008
-
-108.02%(-12.6%)
Mar 2008
-
-123.63%(+7.7%)
Dec 2007
-121.57%(+68.9%)
-114.77%(-6.4%)
Sep 2007
-
-122.60%(+34.9%)
Jun 2007
-
-90.85%(+46.6%)
Mar 2007
-
-61.98%(+3.6%)
Dec 2006
-71.97%(+4.7%)
-59.85%(-6.9%)
Sep 2006
-
-64.32%(-9.6%)
Jun 2006
-
-71.17%(-17.7%)
Mar 2006
-
-86.46%(+24.9%)
Dec 2005
-68.74%(+6.9%)
-69.21%(+16.0%)
Sep 2005
-
-59.67%(-6.7%)
Jun 2005
-
-63.94%(-14.9%)
Mar 2005
-
-75.15%(-9.4%)
Dec 2004
-64.29%(+11.8%)
-82.98%(+1.9%)
Sep 2004
-
-81.47%(+45.0%)
Jun 2004
-
-56.19%
Dec 2003
-57.49%(+28.9%)
-
Dec 2002
-44.61%(+94.0%)
-
Dec 2001
-23.00%
-

FAQ

  • What is XTL Biopharmaceuticals annual return on assets?
  • What is the all time high annual ROA for XTL Biopharmaceuticals?
  • What is XTL Biopharmaceuticals annual ROA year-on-year change?
  • What is XTL Biopharmaceuticals quarterly return on assets?
  • What is the all time high quarterly ROA for XTL Biopharmaceuticals?
  • What is XTL Biopharmaceuticals quarterly ROA year-on-year change?

What is XTL Biopharmaceuticals annual return on assets?

The current annual ROA of XTLB is -73.45%

What is the all time high annual ROA for XTL Biopharmaceuticals?

XTL Biopharmaceuticals all-time high annual return on assets is 361.82%

What is XTL Biopharmaceuticals annual ROA year-on-year change?

Over the past year, XTLB annual return on assets has changed by -41.25% (-128.11%)

What is XTL Biopharmaceuticals quarterly return on assets?

The current quarterly ROA of XTLB is -26.81%

What is the all time high quarterly ROA for XTL Biopharmaceuticals?

XTL Biopharmaceuticals all-time high quarterly return on assets is 155.53%

What is XTL Biopharmaceuticals quarterly ROA year-on-year change?

Over the past year, XTLB quarterly return on assets has changed by -13.52% (-101.73%)